aprepitant stada 125 mg/80 mg kapsułki twarde
stada arzneimittel ag - aprepitantum - kapsułki twarde - 125 mg/80 mg
posaconazole stada 100 mg tabletki dojelitowe
stada arzneimittel ag - posaconazolum - tabletki dojelitowe - 100 mg
fingolimod stada 0,5 mg kapsułki twarde
stada arzneimittel ag - fingolimodum - kapsułki twarde - 0,5 mg
sitagliptin stada 100 mg tabletki powlekane
stada arzneimittel ag - sitagliptin hydrochloride monohydrate - tabletki powlekane - 100 mg
sitagliptin stada 50 mg tabletki powlekane
stada arzneimittel ag - sitagliptin hydrochloride monohydrate - tabletki powlekane - 50 mg
kinpeygo
stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - przeciw rozwolnieniem, patogenów jelitowych przeciwzapalne / antiinfective - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.
pirfenidon stada 534 mg tabletki powlekane
stada arzneimittel ag - pirfenidonum - tabletki powlekane - 534 mg
pirfenidon stada 267 mg tabletki powlekane
stada arzneimittel ag - pirfenidonum - tabletki powlekane - 267 mg
pirfenidon stada 801 mg tabletki powlekane
stada arzneimittel ag - pirfenidonum - tabletki powlekane - 801 mg
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - okulistyka - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).